Prism Biolab

Japanese, clinical stage biotech developing small molecule therapeutics for cancer and fibrotic diseases.

placeYokohama, Kanagawa Prefecture, Japan calendar_todayFounded 2006 language prismbiolab.com

Social engagement

Social engagement: 865 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Daiwa Corporate Investment.

Investor typeCountShare
Venture capital440%
Private equity440%
Other / undisclosed220%

Recent activity

10 Jun 2026
Event
LINK-J 2026 2026TPD()RIiPSPepMetics®
Coming soon